Oxford Technology 3 VCT PLC
Interim Management Statement
For the six months commencing 1 September 2011
Oxford Technology 3 VCT PLC presents its interim management statement for the period commencing 1st September 2011, as required by the UK Listing Authority's Disclosure and Transparency Rule 4.3.
The Directors reviewed the valuation of its entire portfolio at a Board meeting on 16 December 2011.
The unaudited net asset value per ordinary share as at 16 December 2011 was 71p. This is the same price as the last quarter ending 31 August 2011. The total number of ordinary shares in issue is 6,785,233.
During the quarter new investments were made in Glide Pharma (£25k), Ixaris (£108k), Invro (£10k) and Archimed (£30k). There were no disposals.
The Directors are not aware of any other events or transactions which have taken place between 31 August 2011 and the publication of this statement which have had a material effect on the financial position of the Company.
19 December 2011
Enquiries:
Lucius Cary, Oxford Technology Management
01865 784466